No headlines found.
No press releases found.
No news found.
The Cambria Cannabis ETF seeks capital appreciation from investments in the global equity markets that have exposure to the broad cannabis industry. The Fund will target investing in approximately 20 to 50 of the top companies with exposure to the broad cannabis industry based on Cambria s determination as to their exposure to the industry. The Fund generally expects to invest in companies across a broad market capitalization spectrum of micro-, small-, and mid-capitalization stocks.
Cambria Cannabis ETF trades on the BATS stock market under the symbol TOKE.
As of April 1, 2026, TOKE stock price climbed to $5.27 with 1,774 million shares trading.
TOKE has a beta of 0.85, meaning it tends to be less sensitive to market movements. TOKE has a correlation of 0.14 to the broad based SPY ETF.
TOKE has a market cap of $15.55 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, TOKE traded as high as $7.47 and as low as $3.86.
TOKE has underperformed the market in the last year with a price return of +18.4% while the SPY ETF gained +18.6%. TOKE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.4% and -3.1%, respectively, while the SPY returned -3.5% and -1.9%, respectively.
TOKE support price is $4.92 and resistance is $5.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TOKE shares will trade within this expected range on the day.
